MaxVal Blog

    Filter by Category
    Filter by Category

    Go Back to Homepage

    Recent advances in Life Sciences | May 2018 Newsletter | MaxVal

    Hot Topics May

    The article presents a base editing approach to expand the scope and efficiency of CRISPR mediated genome editing.

    It highlights recent FDA approval for a trial involving Artificial Intelligence-powered insulin infusion device for diabetes management.

    Go Back to Homepage

    MaxVal to Sponsor and Exhibit at IPBC Global, San Francisco (June 10-12, 2018)
    Technology Landscape Study on CRISPR-Cas9

    About Author

    MaxVal
    MaxVal

    Related Posts
    Medtronic’s Transcatheter Aortic Valve Replacement (TAVR) Devices Face Patent Challenge from Speyside Medical
    Medtronic’s Transcatheter Aortic Valve Replacement (TAVR) Devices Face Patent Challenge from Speyside Medical
    Quibi Seeks a Clean Slate Before its Product Launch
    Quibi Seeks a Clean Slate Before its Product Launch
    Click Chemistry | November 2019 Newsletter
    Click Chemistry | November 2019 Newsletter

    Comment